Nihon Kohden

Tokyo, Japan Founded: 1951 • Age: 75 yrs Listed
Manufacturer, Exporter, importer and Supplier of Medical equipment

About Nihon Kohden

Nihon Kohden is a publicly listed company based in Tokyo (Japan) founded in 1951. Manufacturer, Exporter, importer and Supplier of Medical equipment. It operates in the Healthcare and Technology sectors. The company has 6,110 employees. Nihon Kohden has completed 6 acquisitions, including AMP3D, Ad-Tech Medical Instrument and Defibtech. Its website nihonkohden.com draws about 60 thousand monthly visits. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Monitoring Devices.

Company details

Nihon Kohden is a Japanese producer and exporter of medical equipment. Its major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, intraoperative neuromonitoring and hematology analyzers. Nihon Kohden also imports and supplies overseas products into Japan. Their range of imported equipment includes cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine and rehabilitation. In Japan, their extensive domestic sales network consists of over 650 direct sales staff with over 100 offices throughout the country.

Key Metrics
  • Annual Revenue
    $1.47 B (USD)
    4.29
    as on Mar 31, 2026
  • Net Profit
    $90.97 M (USD)
    2.95
    as on Mar 31, 2026
  • EBITDA
    $154.23 M (USD)
    -1.2
    as on Mar 31, 2026
  • Employee Count
    6,110
  • Investments & Acquisitions
    AMP3D

    & 5 more

IPO & Listings of Nihon Kohden

Nihon Kohden is a publicly listed company on the TSE with ticker symbol 6849 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date02 Nov 1961
  • Listed onTSE: 6849
  • Listed entityNihon Kohden Corporation
  • Exchange sectorHealth technology
  • ISINJP3706800004
  • Share price1,652.50 JPY (+0.24% on the day) · 2026-10-14
  • Market capitalisation270,259,521,149.00 JPY
  • Price to earnings19.7
  • EPS (diluted, trailing year)83.69 JPY
  • Dividend yield1.95%
  • Volume (last session)788,100

Financials of Nihon Kohden

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025235.10B JPY14.51B JPY24.60B JPY
2024225.42B JPY14.10B JPY24.90B JPY
2023221.99B JPY17.03B JPY23.45B JPY
2022206.60B JPY17.11B JPY24.91B JPY
2021205.13B JPY23.43B JPY34.48B JPY
Premium access

Detailed financial statements for Nihon Kohden

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Nihon Kohden

Nihon Kohden has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include AMP3D, Ad-Tech Medical Instrument and Defibtech.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Neurosurgical instruments and electrodes are developed for epilepsy treatment.
adtechmedical.comRacine, United States1983Dec 2024β€’β€’β€’β€’
neuroadvancedcorp.tcc.mode0Nov 2024β€’β€’β€’β€’
SaaS-based Big Data analytics platform for earlier intervention of potentially catastrophic events with sub-acute prodrome
amp3d.bizCharlottesville, United States2014Aug 2021β€’β€’β€’β€’
AEDs and resuscitation products are designed and manufactured.
defibtech.comGuilford, United States1999Oct 2012β€’β€’β€’β€’
Sleep diagnostic devices and software are developed for portable use.
neurotronics.comGainesville, United States1971Dec 2008β€’β€’β€’β€’
Pathology lab services are delivered via a chain in Mexico.
labnova.comDurango, Mexico2007May 2006β€’β€’β€’β€’
Premium access

Complete acquisition details for Nihon Kohden

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Nihon Kohden

8 dated milestones of Nihon Kohden across 73 years, from founding to its latest funding, stage changes and deals.

  1. Founded Nihon Kohden is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Laboratorio Nova.
  4. Acquisition Acquires Neurotronics.
  5. Acquisition Acquires Defibtech.
  6. Acquisition Acquires AMP3D.
  7. Acquisition Acquires Neuroadvancedcorp.
  8. Acquisition Acquires Ad-Tech Medical Instrument.

Web traffic of Nihon Kohden

The website of Nihon Kohden (nihonkohden.com) receives about 60.5K visits a month.

  • Monthly visits
    60.5K

    ▼ 23% vs previous month

Similar websites

Websites whose visitors overlap most with Nihon Kohden. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nkusa.com
nkusa.com
100%
–
medical.philips.com
medical.philips.com
96%
–
maquet.ru
maquet.ru
87%
–
neurosoft.ru
neurosoft.ru
87%
–
alcon.com
87%
171K#286,128View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Nihon Kohden

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nihon Kohden

Premium access

Complete news archive for Nihon Kohden

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nihon Kohden

Nihon Kohden was founded in 1951.

Nihon Kohden is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.

Nihon Kohden has 6,110 employees.

Annual revenue of Nihon Kohden is $1.47B as on Mar 31, 2026.

Nihon Kohden is a Japanese producer and exporter of medical equipment. Its major product lines for export are patient monitors, electroencephalographs, evoked potential and electromyograph systems, electrocardiographs, defibrillators, intraoperative neuromonitoring and hematology analyzers. Nihon Kohden also imports and supplies overseas products into Japan. Their range of imported equipment includes cardiology, urology, respiratory care, anesthesiology, emergency care, sports medicine and rehabilitation. In Japan, their extensive domestic sales network consists of over 650 direct sales staff with over 100 offices throughout the country.

Yes, Nihon Kohden is publicly traded on TSE under the ticker symbol 6849.

Nihon Kohden has made 6 acquisitions, including AMP3D, Ad-Tech Medical Instrument, and Defibtech.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available